VEEVBULLISH

Revenue Growth (YoY)

16.3%

Higher than 83% of Healthcare sector peers

Updated 22h ago

Sector Performance

83th percentile

VEEV

16.3%

Sector Median

6.2%

Sector Avg

3.8%

📊

Deep Analysis

Veeva Systems’ current Revenue Growth (YoY) of 16.3% means its revenue increased by 16.3% compared to the same quarter last year — a measure of how fast the top line is expanding.

This rate places the company well above its healthcare sector peers, where the median is 6.2%, ranking Veeva at the 82nd percentile among those peers. While the year-over-year change in the metric itself is listed as N/A (not available), the most recent two quarterly values — 16.3% and 16.0% — show a slight sequential uptick, and the quarter-over-quarter change of +1.9% confirms a modest acceleration. Combining a growth rate that is nearly triple the sector median with a rising trend points to a low-risk opportunity: the company is not only outperforming but also building on that lead. This metric directly supports the overall BULLISH verdict, as strong revenue growth is a core driver of investor confidence and stock valuation.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about VEEV?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does VEEV's Revenue Growth (YoY) compare to its sector?

VEEV's Revenue Growth (YoY) of 16.3% compares to a Healthcare sector median of 6.2%, placing it in the 83th percentile.

Who are VEEV's closest peers by Revenue Growth (YoY)?

The closest Healthcare peers by Revenue Growth (YoY) include: AMGN (5.8%), CPRX (5.6%), HIMS (3.8%), BAX (2.9%), BMY (2.6%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.